Shandong Sanyuan Biotechnology Co.Ltd. Total Liabilities
Shandong Sanyuan Biotechnology Co.Ltd. total liabilities. Based on the latest financial reports, Shandong Sanyuan Biotechnology Co.Ltd. (301206) has total liabilities worth CN¥166.97 Million CNY (≈ $24.43 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Shandong Sanyuan Biotechnology Co.Ltd. defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Shandong Sanyuan Biotechnology Co.Ltd. (2013–2024)
Total liabilities of Shandong Sanyuan Biotechnology Co.Ltd. from 2013 to 2024. This chart illustrates how Shandong Sanyuan Biotechnology Co.Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Check 301206 financial resilience to evaluate the company's liquid asset resilience ratio.
Shandong Sanyuan Biotechnology Co.Ltd. Competitors by Total Liabilities
The table below lists competitors of Shandong Sanyuan Biotechnology Co.Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sunyard System Engineering Co Ltd
SHG:600571
|
China | CN¥764.96 Million |
|
JNTC Co. Ltd
KQ:204270
|
Korea | ₩300.47 Billion |
|
Ramkhamhaeng Hospital Public Company Limited
BK:RAM
|
Thailand | ฿22.65 Billion |
|
Achieve Life Sciences Inc
NASDAQ:ACHV
|
USA | $22.43 Million |
|
Covenant Logistics Group, Inc.
NYSE:CVLG
|
USA | $592.89 Million |
|
Lanzhou Haimo Technologies Co
SHE:300084
|
China | CN¥258.19 Million |
|
Dodla Dairy Limited
NSE:DODLA
|
India | Rs4.01 Billion |
|
Shenzhen Kiwi Instruments Co. Ltd. A
SHG:688045
|
China | CN¥407.40 Million |
Liability Composition Analysis (2013–2024)
This chart breaks down Shandong Sanyuan Biotechnology Co.Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Shandong Sanyuan Biotechnology Co.Ltd. assets under control.
Liquidity & Leverage Metrics
Shandong Sanyuan Biotechnology Co.Ltd. Total Liabilities Ratios Explained
Shandong Sanyuan Biotechnology Co.Ltd. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 21.08 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Sanyuan Biotechnology Co.Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Sanyuan Biotechnology Co.Ltd. (2013–2024)
The table below shows the annual total liabilities of Shandong Sanyuan Biotechnology Co.Ltd. from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥314.04 Million ≈ $45.95 Million |
+15.29% |
| 2023-12-31 | CN¥272.40 Million ≈ $39.86 Million |
+9.34% |
| 2022-12-31 | CN¥249.14 Million ≈ $36.46 Million |
-57.69% |
| 2021-12-31 | CN¥588.83 Million ≈ $86.16 Million |
+116.90% |
| 2020-12-31 | CN¥271.48 Million ≈ $39.73 Million |
+54.61% |
| 2019-12-31 | CN¥175.59 Million ≈ $25.69 Million |
+75.38% |
| 2018-12-31 | CN¥100.12 Million ≈ $14.65 Million |
+53.29% |
| 2017-12-31 | CN¥65.31 Million ≈ $9.56 Million |
+61.52% |
| 2016-12-31 | CN¥40.44 Million ≈ $5.92 Million |
+64.09% |
| 2015-12-31 | CN¥24.64 Million ≈ $3.61 Million |
-19.67% |
| 2014-12-31 | CN¥30.68 Million ≈ $4.49 Million |
+60.62% |
| 2013-12-31 | CN¥19.10 Million ≈ $2.79 Million |
-- |
About Shandong Sanyuan Biotechnology Co.Ltd.
Shandong Sanyuan Biotechnology Co.,Ltd. engages in the research and development, production, and sale of erythritol and compound sugar products in China. Its products are used in table sugar, flavored sugar, and beverages; candy and chocolate food; baked food; health food; medical supplies; cosmetic products; chemical products; and other applications. The company exports its products to Europe, t… Read more